Published in World J Surg on May 01, 2007
Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg (2009) 1.59
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 1.23
Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg (2008) 1.02
Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital. J Thyroid Res (2011) 0.84
Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J Surg (2012) 0.82
Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J Cancer Res Clin Oncol (2017) 0.82
Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy. Med Sci Monit (2016) 0.80
Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma. World J Surg (2008) 0.78
Prognostic Value of Extranodal Extension in Thyroid Cancer: A Meta-Analysis. Yonsei Med J (2016) 0.78
Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital. Surg Today (2011) 0.76
The Effectiveness of Prophylactic Modified Neck Dissection for Reducing the Development of Lymph Node Recurrence of Papillary Thyroid Carcinoma. World J Surg (2017) 0.75
Thyroid ultrasonography. World J Surg (2010) 0.75
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery (1988) 3.27
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab (1990) 3.02
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67
Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer (2006) 2.46
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1991) 2.04
Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med (1981) 1.99
Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg (2001) 1.89
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84
Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg (2006) 1.79
Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg (1995) 1.78
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg (1998) 1.35
Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer (1970) 1.34
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg (2004) 1.16
Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg (1985) 1.16
Risk factor analysis in differentiated thyroid cancer. Cancer (1979) 1.14
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid (1995) 1.08
Selection of surgical treatment for well differentiated thyroid carcinomas. Ann Surg (1972) 1.08
Survival discriminants for differentiated thyroid cancer. Am J Surg (1990) 1.07
Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery (1995) 1.04
Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg (1996) 1.02
Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol (1998) 1.01
Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg (1978) 0.99
Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer (2004) 0.98
Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid (1995) 0.98
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Importance of lymph node metastases in follicular thyroid cancer. World J Surg (2002) 0.96
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer (2002) 0.95
Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg (1992) 0.93
Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope (2004) 0.93
Surgery of thyroid cancer. World J Surg (1981) 0.91
Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery (1993) 0.89
Prognosis in thyroid carcinoma. Cancer (1975) 0.88
Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits? Langenbecks Arch Surg (1998) 0.88
14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett (2003) 0.87
Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid (2005) 0.86
Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer (2002) 0.86
Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age. Br J Surg (1986) 0.86
Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma. Pathol Res Pract (2005) 0.85
Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res (1997) 0.84
Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer (1991) 0.83
Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology (2005) 0.83
Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg (1996) 0.82
Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol (2006) 0.82
Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg (1988) 0.82
[Guidelines in oncologic surgery--malignant thyroid tumors]. Langenbecks Arch Chir Suppl Kongressbd (1997) 0.81
Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today (2004) 0.81
[Lymph node excision in thyroid carcinoma]. Chirurg (1996) 0.81
Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg (1990) 0.80
Significance of mediastinal lymph node metastases in carcinoma of the thyroid. Am J Surg (1972) 0.80
Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet (1980) 0.80
Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg (2000) 0.77
Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis. Eur J Surg Oncol (1999) 0.77
Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl (2003) 0.76
Changing the operative strategy for thyroid cancer by node sampling. Am J Surg (1983) 0.75
Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer Clin Oncol (1988) 0.75
Modified neck dissection in the treatment of differentiated thyroid carcinoma. Eur J Surg Oncol (1997) 0.75
Transsternal radical neck dissection. Postoperative complications and management. Arch Otolaryngol (1975) 0.75
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope (2011) 2.55
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med (2006) 1.90
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J (2011) 1.72
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J (2006) 1.49
Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med (2005) 1.49
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2007) 1.49
Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid (2009) 1.48
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol (Oxf) (2009) 1.47
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg (2012) 1.47
Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J (2004) 1.46
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg (2006) 1.46
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J (2004) 1.41
External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement. Laryngoscope (2013) 1.40
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett (2006) 1.38
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32
Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J Surg (2005) 1.30
Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am (2006) 1.29
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg (2005) 1.25
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg (2010) 1.22
The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet (2011) 1.20
Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J (2009) 1.19
Tumor thrombus of thyroid malignancies in veins: importance of detection by ultrasonography. Thyroid (2011) 1.18
Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol (2007) 1.18
Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med (2008) 1.18
Autonomic dysreflexia associated with Charcot spine following spinal cord injury: a case report and literature review. Eur Spine J (2010) 1.17
Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab (2013) 1.16
Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid (2010) 1.15
Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery (2008) 1.15
Menstrual disturbances in various thyroid diseases. Endocr J (2010) 1.14
Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. Thyroid (2008) 1.13
Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab (2006) 1.12
Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol (2012) 1.11
Acute suppurative thyroiditis after fine-needle aspiration causing thyrotoxicosis. Thyroid (2005) 1.07
Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res (2007) 1.05
Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid (2007) 1.05
Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid (2002) 1.05
Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol (2003) 1.05
Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg (2008) 1.04
VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol (2005) 1.04
Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg (2007) 1.03
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis (2002) 1.03
Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg (2008) 1.02
Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol (Oxf) (2012) 1.02
Surgical outcomes of posterior lumbar interbody fusion in elderly patients. Surgical technique. J Bone Joint Surg Am (2007) 1.02
Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett (2005) 1.02
Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol (2009) 1.01
Reevaluation of stringent low iodine diet in outpatient preparation for radioiodine examination and therapy. Endocr J (2005) 1.01
Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg (2007) 1.01
Evaluation of chemocauterization treatment for obliteration of pyriform sinus fistula as a route of infection causing acute suppurative thyroiditis. Thyroid (2009) 1.01
Prognostic factors of anaplastic thyroid carcinoma. Surg Today (2004) 1.00
Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid. Anticancer Res (2003) 1.00
Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today (2006) 1.00
BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? World J Surg (2014) 1.00
Successful treatment for recurrent painful Hashimoto's thyroiditis by total thyroidectomy. Thyroid (2005) 1.00
Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. Am J Physiol Endocrinol Metab (2009) 0.99
Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Endocr J (2005) 0.98
Acute suppurative thyroiditis caused by an infected piriform sinus fistula with thyrotoxicosis. Thyroid (2002) 0.98
Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. Cancer Lett (2003) 0.98
Needle tract implantation of papillary thyroid carcinoma after fine-needle aspiration biopsy. World J Surg (2005) 0.98
Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies. Biochem Biophys Res Commun (2008) 0.98
Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease. Clin Endocrinol (Oxf) (2007) 0.98
Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg (2007) 0.98
Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Ann Surg Oncol (2005) 0.97
Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan. Endocr J (2009) 0.97
Charcot spinal disease after spinal cord injury. J Neurosurg Spine (2008) 0.97
Parathyroid gland involvement by papillary carcinoma of the thyroid gland. Arch Pathol Lab Med (2002) 0.97
Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J (2012) 0.97
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int J Oncol (2013) 0.97
Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study. Endocr J (2012) 0.96
Sensitivity and specificity of intraoperative recurrent laryngeal nerve stimulation test for predicting vocal cord palsy after thyroid surgery. World J Surg (2006) 0.96
Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab (2006) 0.96
TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur J Endocrinol (2012) 0.96
Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg (2004) 0.96
Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J Surg (2010) 0.95
Repair of cervical esophageal perforation using longus colli muscle flap: a case report of a patient with cervical spinal cord injury. Spine J (2007) 0.95
Cribriform-morular variant of papillary thyroid carcinoma--cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol (2010) 0.95
Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology (2008) 0.95
Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid (2007) 0.95
Cytologic features of hyalinizing trabecular adenoma of the thyroid. Acta Cytol (2003) 0.94